NTCOC
SLXP

Northern Trust Company of Connecticut’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Northern Trust Company of Connecticut’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$6.83M Buy
75,953
+22,383
+42% +$1.79M 0.04% 571
2013
Q3 		$3.58M Sell
53,570
-31,421
-37% -$2.17M 0.02% 818
2013
Q2 		$5.62M Buy
+84,991
New +$4.86M 0.04% 633

Other funds holding SLXP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Northern Trust Company of Connecticut's SLXP Position: Q4 2013 in Review

Northern Trust Company of Connecticut increased its SALIX PHARMACEUTICALS LTD DEL (SLXP) stake by 42% in Q4 2013, buying an estimated $1.79M and bringing the position to 75,953 shares worth $6.83M. The position accounts for 0.04% of the portfolio, ranked #571.

Northern Trust Company of Connecticut first reported a position in SLXP in Q2 2013 and has held it in 3 quarters since. 246 funds tracked by Wall St. Rank hold SLXP as of Q4 2013.

  • Northern Trust Company of Connecticut held 75,953 shares of SALIX PHARMACEUTICALS LTD DEL worth $6.83M as of Q4 2013.
  • Northern Trust Company of Connecticut bought 22,383 SALIX PHARMACEUTICALS LTD DEL shares in Q4 2013, an estimated $1.79M.
  • SALIX PHARMACEUTICALS LTD DEL made up 0.04% of Northern Trust Company of Connecticut's portfolio in Q4 2013, its #571 holding.
  • Northern Trust Company of Connecticut first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and has held it in 3 quarters since.
  • 246 funds tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q4 2013.

Based on Northern Trust Company of Connecticut's 13F filing for Q4 2013, filed 12 Feb 2014.